Ertapenem

This classification denotes a beta-lactam antibiotic with the molecular formula C22H25N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G32F6EID2H, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as ertapenem, which bears US NIH Compound Identifier 150610. European Medicines Agency schedules Ertapenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25388. The term ERTAPENEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). World Health Organization schedules ertapenem in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ertapenem under HS 29419000 and SITC 54139. As of Q4 2014, ERTAPENEM remains the US FDA Preferred Term for this commodity. Ertapenem bears US NLM identifiers UMLS ID C1120106 and NCI Concept Code C61752. SMILES: S(C1=C(N2C(C(C2=O)C(O)C)C1C)C(=O)O)C1CC(NC1)C(=O)NC1CC(CCC1)C(=O)O.